Evotec SE (EVO)
USD 4.33
(-9.41%)
USD 4.33
(-9.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 30.89 Million EUR | 3.57% |
| 2022 | 29.82 Million EUR | 15.63% |
| 2021 | 25.79 Million EUR | 89.86% |
| 2020 | 13.58 Million EUR | 26.38% |
| 2019 | 10.74 Million EUR | 89.91% |
| 2018 | 5.66 Million EUR | -37.23% |
| 2017 | 9.01 Million EUR | 109.45% |
| 2016 | 4.3 Million EUR | 37.41% |
| 2015 | 3.13 Million EUR | 0.71% |
| 2014 | 3.11 Million EUR | 31.93% |
| 2013 | 2.35 Million EUR | -3.56% |
| 2012 | 2.44 Million EUR | -31.24% |
| 2011 | 3.55 Million EUR | 26.14% |
| 2010 | 2.81 Million EUR | 16.25% |
| 2009 | 2.42 Million EUR | 13.37% |
| 2008 | 2.13 Million EUR | -10.65% |
| 2007 | 2.39 Million EUR | -49.94% |
| 2006 | 4.78 Million EUR | -54.47% |
| 2005 | 10.5 Million EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| 2001 | - EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 37.34 Million EUR | 17.29% |
| 2024 Q1 | 31.83 Million EUR | 3.07% |
| 2023 FY | 30.89 Million EUR | 3.57% |
| 2023 Q2 | 32.61 Million EUR | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q3 | 31.9 Million EUR | -2.16% |
| 2023 Q4 | 30.89 Million EUR | -3.18% |
| 2022 Q4 | 29.82 Million USD | -3.4% |
| 2022 Q3 | 30.87 Million EUR | 6.48% |
| 2022 Q2 | 28.99 Million EUR | 11.19% |
| 2022 Q1 | 26.07 Million EUR | 1.1% |
| 2022 FY | 29.82 Million EUR | 15.63% |
| 2021 Q4 | 25.79 Million EUR | 14.54% |
| 2021 FY | 25.79 Million EUR | 89.86% |
| 2021 Q2 | 17.25 Million EUR | 13.24% |
| 2021 Q1 | 15.23 Million EUR | 12.16% |
| 2021 Q3 | 22.51 Million EUR | 30.51% |
| 2020 Q2 | 10.59 Million EUR | -2.42% |
| 2020 Q1 | 10.86 Million EUR | 1.03% |
| 2020 Q4 | 13.58 Million EUR | 16.22% |
| 2020 Q3 | 11.68 Million EUR | 10.3% |
| 2020 FY | 13.58 Million EUR | 26.38% |
| 2019 FY | 10.74 Million EUR | 89.91% |
| 2019 Q4 | 10.74 Million EUR | -11.89% |
| 2019 Q3 | 12.2 Million EUR | 87.09% |
| 2019 Q1 | 5.64 Million EUR | -0.3% |
| 2019 Q2 | 6.52 Million EUR | 15.56% |
| 2018 Q4 | 5.66 Million EUR | -16.0% |
| 2018 Q2 | 5.26 Million EUR | -13.8% |
| 2018 FY | 5.66 Million EUR | -37.23% |
| 2018 Q1 | 6.1 Million EUR | -32.33% |
| 2018 Q3 | 6.73 Million EUR | 28.1% |
| 2017 Q2 | 4.43 Million EUR | -4.48% |
| 2017 Q1 | 4.64 Million EUR | 7.87% |
| 2017 FY | 9.01 Million EUR | 109.45% |
| 2017 Q4 | 9.01 Million EUR | -29.66% |
| 2017 Q3 | 12.82 Million EUR | 189.0% |
| 2016 Q1 | 3.7 Million EUR | 18.13% |
| 2016 FY | 4.3 Million EUR | 37.41% |
| 2016 Q4 | 4.3 Million EUR | 5.51% |
| 2016 Q3 | 4.08 Million EUR | 2.56% |
| 2016 Q2 | 3.97 Million EUR | 7.48% |
| 2015 Q1 | 3.77 Million EUR | 21.25% |
| 2015 FY | 3.13 Million EUR | 0.71% |
| 2015 Q3 | 3.68 Million EUR | 13.33% |
| 2015 Q4 | 3.13 Million EUR | -15.07% |
| 2015 Q2 | 3.25 Million EUR | -13.71% |
| 2014 Q1 | 2.89 Million EUR | 22.56% |
| 2014 FY | 3.11 Million EUR | 31.93% |
| 2014 Q4 | 3.11 Million EUR | -6.21% |
| 2014 Q3 | 3.31 Million EUR | 17.5% |
| 2014 Q2 | 2.82 Million EUR | -2.32% |
| 2013 Q1 | 2.8 Million EUR | 14.85% |
| 2013 Q4 | 2.35 Million EUR | -14.75% |
| 2013 FY | 2.35 Million EUR | -3.56% |
| 2013 Q3 | 2.76 Million EUR | 4.14% |
| 2013 Q2 | 2.65 Million EUR | -5.41% |
| 2012 Q4 | 2.44 Million EUR | -44.97% |
| 2012 Q1 | 3.42 Million EUR | -3.6% |
| 2012 Q2 | 3.48 Million EUR | 1.63% |
| 2012 Q3 | 4.44 Million EUR | 27.53% |
| 2012 FY | 2.44 Million EUR | -31.24% |
| 2011 Q3 | 3.23 Million EUR | -1.1% |
| 2011 Q4 | 3.55 Million EUR | 10.06% |
| 2011 Q1 | 2.92 Million EUR | 3.87% |
| 2011 Q2 | 3.26 Million EUR | 11.58% |
| 2011 FY | 3.55 Million EUR | 26.14% |
| 2010 Q4 | 2.81 Million EUR | -3.23% |
| 2010 FY | 2.81 Million EUR | 16.25% |
| 2010 Q3 | 2.91 Million EUR | 7.17% |
| 2010 Q2 | 2.71 Million EUR | -9.76% |
| 2010 Q1 | 3.01 Million EUR | 24.21% |
| 2009 Q4 | 2.42 Million EUR | 7.49% |
| 2009 Q1 | 2.39 Million EUR | 12.11% |
| 2009 Q2 | 2.34 Million EUR | -2.38% |
| 2009 Q3 | 2.25 Million EUR | -3.63% |
| 2009 FY | 2.42 Million EUR | 13.37% |
| 2008 Q2 | 2.81 Million EUR | -21.43% |
| 2008 Q4 | 2.13 Million EUR | -15.9% |
| 2008 Q3 | 2.54 Million EUR | -9.63% |
| 2008 FY | 2.13 Million EUR | -10.65% |
| 2008 Q1 | 3.58 Million USD | 49.39% |
| 2007 FY | 2.39 Million EUR | -49.94% |
| 2007 Q3 | 3.01 Million EUR | 0.0% |
| 2007 Q4 | 2.39 Million EUR | -20.52% |
| 2006 Q3 | - EUR | 0.0% |
| 2006 Q2 | - EUR | 0.0% |
| 2006 Q4 | 4.78 Million EUR | 0.0% |
| 2006 FY | 4.78 Million EUR | -54.47% |
| 2006 Q1 | - EUR | 0.0% |
| 2005 FY | 10.5 Million EUR | 0.0% |
| 2005 Q2 | - EUR | 0.0% |
| 2005 Q1 | - EUR | 0.0% |
| 2005 Q4 | - EUR | 0.0% |
| 2004 Q1 | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2004 Q4 | - EUR | 0.0% |
| 2004 Q2 | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2003 Q4 | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| 2001 FY | - EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -570.158% |
| Harrow Health, Inc. | 10.86 Million USD | -184.255% |
| Dynavax Technologies Corporation | 53.29 Million USD | 42.034% |
| Biofrontera Inc. | 10.9 Million USD | -183.187% |
| DURECT Corporation | 2.21 Million USD | -1292.068% |
| Cronos Group Inc. | 30.33 Million USD | -1.816% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -3088999900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -442.022% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -1053.855% |
| Radius Health, Inc. | 278.64 Million USD | 88.914% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -823.947% |
| ProPhase Labs, Inc. | 3.84 Million USD | -704.218% |
| Phibro Animal Health Corporation | 265.91 Million USD | 88.383% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -3714.725% |
| Procaps Group S.A. | 96.83 Million USD | 68.1% |
| Alvotech | 74.43 Million USD | 58.5% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Rockwell Medical, Inc. | 5.87 Million USD | -426.145% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -438.646% |
| Alpha Teknova, Inc. | 11.59 Million USD | -166.431% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -165.219% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -144.518% |
| Theratechnologies Inc. | 6.06 Million USD | -409.232% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 72.22% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -1036.079% |
| Safety Shot Inc | 1.86 Million USD | -1552.184% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 60.095% |
| SIGA Technologies, Inc. | 64.21 Million USD | 51.898% |
| Tilray Brands, Inc. | 252.08 Million USD | 87.746% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 22.734% |
| Viatris Inc. | 3.46 Billion USD | 99.11% |
| PetIQ, Inc. | 159.3 Million USD | 80.61% |
| OptiNose, Inc. | 8.05 Million USD | -283.631% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 19.347% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -438.646% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -9.334% |
| Alimera Sciences, Inc. | 1.87 Million USD | -1543.96% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 4.46% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 18.033% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Cosmos Health Inc. | 4.78 Million USD | -545.013% |
| Journey Medical Corporation | 10.2 Million USD | -202.665% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -1818.168% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -589.048% |
| Embecta Corp. | 152.1 Million USD | 79.691% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 20318.88% |
| Procaps Group, S.A. | 96.83 Million USD | 68.1% |
| PainReform Ltd. | - USD | -Infinity% |
| Incannex Healthcare Limited | -10.01 Million USD | 408.437% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -12044.587% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -197.592% |
| Shineco, Inc. | 1.58 Million USD | -1844.571% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 70.399% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -356.345% |
| Alvotech | 74.43 Million USD | 58.5% |
| Hempacco Co., Inc. | 2.54 Million USD | -1114.885% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 35.368% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 51.756% |
| Bright Green Corporation | - USD | -Infinity% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 52.928% |
| Kamada Ltd. | 87.74 Million USD | 64.796% |
| Indivior PLC | 141.79 Million USD | 78.216% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -6310.842% |
| Flora Growth Corp. | 8.5 Million USD | -263.07% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -12044.587% |
| Evolus, Inc. | 10.99 Million USD | -180.869% |
| HUTCHMED (China) Limited | 50.25 Million USD | 38.537% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 70.813% |
| Akanda Corp. | 1.28 Million USD | -2300.353% |